Publications by authors named "Jacques Vignon"

Claim this Profile
P
Phostine PST3.1a Targets MGAT5 and Inhibits Glioblastoma-Initiating Cell Invasiveness and Proliferation.
Zahra Hassani, Ali Saleh, Soumaya Turpault, Salim Khiati, Willy Morelle, Jacques Vignon

Mol Cancer Res· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of NMDAR antagonists with reduced neurotoxic side effects: a study on GK11.
Delphine Vandame, Lauriane Ulmann, Marisa Teigell, Monica Prieto-Cappellini, Jacques Vignon

PLoS One· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of purinergic P2Y receptor subtypes by INS-1 insulinoma beta-cells: a molecular and binding characterization.
Laura Lugo-Garcia, Romain Filhol, Anne-Dominique Lajoix, René Gross, Pierre Petit, Jacques Vignon

Eur J Pharmacol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
P2Y receptor mediated modulation of insulin release by a novel generation of 2-substituted-5'-O-(1-boranotriphosphate)-adenosine analogues.
Anne Farret, Romain Filhol, Nathalie Linck, Michèle Manteghetti, Jacques Vignon

Pharm Res· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute exposure to GSM 900-MHz electromagnetic fields induces glial reactivity and biochemical modifications in the rat brain.
Anne-Laure Mausset-Bonnefont, Hélène Hirbec, Xavier Bonnefont, Alain Privat, Jacques Vignon

Neurobiol Dis· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re-evaluation of phencyclidine low-affinity or "non-NMDA" binding sites.
Hélène Hirbec, Anne-Laure Mausset, Jean Marc Kamenka, Alain Privat, Jacques Vignon

J Neurosci Res· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis